Many organizations are evaluating how advanced therapy medicinal products (ATMPs) and other traditional modalities may be combined within the same facility or within a newly constructed agnostic building. This article outlines a broad framework to evaluate different types of modalities that may be accommodated concurrently in a new or existing facility and then uses a case study to explain how...
Has it really been a year since I began my term as Chair of the ISPE International Board of Directors? It seems like yesterday, and now the
We don’t often take time for reflection, except when in times of trial or transition. I recently needed to update my resume, which forced some reflection on what I had done of note since my last update. This reminded me that we are coming up on the end of the year, a transition to new leadership and new goals, and maybe even cleaning up our toolboxes.
The inclusive nature of ISPE promotes diversity in thought, providing pharma professionals of all levels, geographic, and cultural backgrounds the opportunity to share their knowledge and collaborate across borders. ISPE’s...
